IRIDEX Corporation IRIX
NASDAQ · United States · Health Technology
$0.6430+0.01 (+1.74%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Despite a 7% revenue dip from retina headwinds, IRIDEX Corp (IRIX) posts record glaucoma probe volume and reaffirms full-year guidance.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Moby summary of IRIDEX Corporation's Q2 2026 earnings call
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.